Full Article: Ion Mobility Spectrometry for Determination of Active Drug in Blinded Dosage Forms
Source: Smiths Detection
Clinical trials are an important part of
the drug product development process.
While the physical attributes of commercially
available tablets and capsules
may be useful for identification of drug
products, the unique appearance of these
dosage forms can be problematic in clinical
trials, especially when the studies
collect subjective data...
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online